Sodium chloride, infusion solution, 9 mg/ml 200 ml, Ringeria Lactate powder for injections, 200 ml, Chloramphenicol/methyluracil oil, 7,5 mg/40 mg/ml, Lactulose, syrup, 670 mg/ml, 200 ml in flacon No 1, Decametason, solution for injections 4 mg/ml, Ceftriaxone, powder for injections 10 g, Metrocombone tablet, tablet for infusion, 5 mg/ml, Mupirosine tablet, 2 mg/ml, 2 mg, 15 mg, creatinine, Lipolithic OD: 8000 mg, Acidic acid tablets, 50 mg/ml, 50 mg/ml, 50 mg/ml, 50 mg/ml, 50 mg/ml, 50 mg/ml, 5
- 采购方
- prozorro_gov_ua
- 机构全称
- The company is a publicly traded company , and it is a publicly traded company .
- 国家/地区
- Ukraine
- 截止时间
- 2026-11-06
- 发布时间
- 2026-11-04
- 公告编号
- UA-2026-11-04-015913-a
- 预算/金额
- 615.45
- 来源编号
- PROZORRO-UA-2026-11-04-015913-a
公告概况
Sodium chloride, infusion solution, 9 mg/ml 200 ml, Ringeria Lactate powder for injections, 200 ml, Chloramphenicol/methyluracil oil, 7,5 mg/40 mg/ml, Lactulose, syrup, 670 mg/ml, 200 ml in flacon No 1, Decametason, solution for injections 4 mg/ml, Ceftriaxone, powder for injections 10 g, Metrocombo
查看完整公告
完整描述、联系方式与采购文件需登录后查看。